Table 1 Demographics, anthropometric parameters and clinical characteristics of virologically suppressed HIV-infected and un-infected control participants in the study

Age (yrs.)

43.73 ± 8.74

43.47 ± 8.87

 Male (%)

41 (27.3)

23 (46)

 Female (%)

109 (72.7)

27 (54)

 ABI

0.92 ± 0.08

0.94 ± 0.05

 SBP (mmHg)

121 ± 21

116 ± 17

 DBP (mmHg)

81 ± 8

76 ± 6

 BMI (kg/m²)

25.43 ± 5.46

25.67 ± 4.93

 BMI 18.5–24. kg/m² (%)

78 (52)

26 (52)

 BMI 25–29.9 kg/m² (%)

38 (25.3)

13 (26)

 BMI ≥ 30 kg/m² (%)

34 (22.7)

11 (22)

 WC (cm)

90.13 ± 11.52

90.58 ± 11.13

 WHR

0.88 ± 0.048

0.88 ± 0.053

 Duration of HIV infection (yrs.)

7.73 ± 3.52

N/A

 Duration on ART (yrs.)

7.47 ± 3.42

N/A

 Nadir CD4⁺ T cell count (cells/mm³)

263 ± 230

N/A

 Current CD4⁺ T cell count (cells/mm³⁾

505 ± 266

N/A

 HIV viral RNA count (copies/ml)

40.95 ± 111.61

N/A

 Undetectable viremia (< 20 copies/ml)

104 (69.3)

 Detectable viremia (≥20 copies/ml)

46 (30.7)

N/A

 NRTI/NNRTI (AZT/3TC/NVP) (%)

93 (62.0)

N/A

 NRTI/NNRTI (TDF/3TC/EFV) (%)

46 (30.7)

N/A

 NRTI/Protease inhibitor (TDF/3TC/LPV/r) (%)

11 (7.3)

N/A